Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb;51(2):226-239.
doi: 10.18502/ijph.v51i2.8677.

Polymeric Nanoparticles in Cancer Chemotherapy: A Narrative Review

Hossein Ali Yousefi Rizi  1   2 , Dong Hoon Shin  3 , Shima Yousefi Rizi  4
Affiliations
Review

Polymeric Nanoparticles in Cancer Chemotherapy: A Narrative Review

Hossein Ali Yousefi Rizi et al. Iran J Public Health. 2022 Feb.

Abstract

Chemotherapy is a common treatment technique that uses chemical drugs to kill cancer cells. This technique affects normal healthy tissues being unspecific and has toxic adverse effects. Nowadays, nanotechnology applications in cancer chemotherapy have helped to solve the uncontrolled problems involving distribution of medicine particles and other side effects. Nanoparticles (NPs) can offer significant advantages over conventional drug delivery to have magnificent properties such as controlled mode of action, various methods of administration, and the ability to transport both organic/inorganic drug particles. Special ligands containing polymeric NPs preferentially hit the tumour site because of their chemical affinity to malignant tissues. This article, reviews the fabrication, characterization, and applications of NPs being used in chemotherapy. Furthermore, different forms of polymeric and especially polymeric chemotherapy were also explored and discussed to understand better the effects of NPs on cancer chemotherapy.

Keywords: Cancer therapy; Chemotherapy; Drug delivery; Magnetic nanoparticles; Polymeric nanoparticles.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The author declares no potential conflict of interest.

Figures

Fig. 1:
Fig. 1:
Morphology of some biodegradable Nano polymers (23,24) Various biodegradable polymers have been approved with zero toxicity and good pharmacokinetics (25,26). However, there are undoubtedly toxicities (27,28)
Fig. 2:
Fig. 2:
The types of Nano based biodegradable natural polymers (27,28, 32)
Fig. 3:
Fig. 3:
The various type of multifunctional nanocarriers for cancer therapy include diagnostics, imaging, reporter molecules, humoral marker, targeting molecules, therapeutic radionuclide, CTX drugs delivery (32,38, 48)
Fig. 4:
Fig. 4:
Schematic showing various techniques for the preparation of PNPs (55,56, 58)
Fig. 5:
Fig. 5:
The representation of different polymers being used as carriers of anticancer drugs to the target tissue (70,74)
Fig. 6:
Fig. 6:
Co-delivery system of PNPs drug loading (81)
Fig. 7:
Fig. 7:
A general schematic showing administration of different coating polymers being used as Polydopamine nanocarriers (86)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Yan L, Shen J, Wang J, Yang X, Dong S, Lu S. (2020). Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology. Dose Response, 18 (3): 1559325820936161. doi:10.1177/1559325820936161 - DOI - PMC - PubMed
    1. Cheng Z, Li M, Dey R, Chen Y. (2021). Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol, 14 (1):85. doi:10.1186/S13045-021-01096-0 - DOI - PMC - PubMed
    1. Siegel RL, Miller KD, Jemal A. (2019). Cancer statistics, 2019. CA Cancer J Clin, 69 (1):7–34. - PubMed
    1. Miller KD, Nogueira L, Mariotto AB, et al. (2019). Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin, 69 (5):363–385. - PubMed
    1. Ferlay J, Colombet M, Soerjomataram I, et al. (2021). Cancer statistics for the year 2020: An overview. Int J Cancer, doi:10.1002/ijc.33588 - DOI - PubMed

LinkOut - more resources